Autologous Fat Grafting Market
Autologous Fat Grafting Market Analysis By Product (Integrated Fat Transfer Systems, Aspiration and Harvesting Systems, Liposuction Systems, Fat Processing Systems, De-epithelialization Devices), By Application & Region - Global Market Insights 2021 to 2031
Market Outlook of Autologous Fat Grafting
The global autologous fat grafting market is projected to expand at a healthy CAGR of close to 10% from 2021 to 2031. By application, breast augmentation holds the highest market share of over 45%.
Autologous fat grafting systems are used for precise and faster fat processing, which eliminates the use of laborious manual procedures. This makes the overall fat grafting process effective and more affordable. Autologous fat transfer systems and accessories find major application in minimal and non-invasive cosmetic procedures.
Fact.MR, in its revised research report, tracks the global sales of autologous fat grafting in 20+ high-growth markets, with North America and Europe the largest regional markets.
A comprehensive assessment of some of the major challenges and unique growth factors have been analyzed. This edition (2021-2031) brings readers up-to-date with key trends of autologous fat grafting, providing analysis on how manufacturers and other stakeholders are reacting to change. The study also expands on the previous competitive landscape section, and readers will get to know the key strategies of established players as well as new entrants in the grafting market.
Avail customized purchase options for your needs
Future Growth Projections Look Positive
In 2020, the global autologous fat grafting market was valued at US$ 172 Mn, and has been expanding at a CAGR of around 8% over the past 10 years. Increasing demand for integrated fat transfer systems was amongst the key factors driving market growth. Increase in awareness about cosmetic surgeries and growing demand for non-invasive procedures led to rising demand for autologous fat grafting.
There has been a considerable impact of COVID19 on autologous fat grafting as these procedures are considered as non-priority treatment and services. The impact of COVID19 on the global economy, less medical tourism, and low availability of manpower hampered market growth adversely. However, over the long-term, the market is projected to progress at an impressive CAGR of close to 10% through 2031.
How Will Product Launches Impact Growth of Autologous Fat Grafting Market?
Over the last few years, leading players in the systems and accessories of autologous fat grafting have received regulatory approvals across major regional markets. New product launches in the market come with new technology, which simplifies treatment procedures and provides improved results to patients.
- For instance, in 2019, Alma Lasers, Inc. introduced BeautiFill - the first laser-based system for autologous fat transfer in the U.S.
- In 2018, USFDA approved the Microfragmented Adipose Tissue System of Lipogem. This micro-fragmented adipose tissue system utilizes body fat to support tissue repair in orthopedic and arthroscopic surgeries.
An Adaptive Approach to Modern-day Research Needs
How are Complications Associated with Post-autologous Fat Grafting Hampering Market Growth?
Over the years, autologous fat grafting has emerged as a popular cosmetic reconstruction technique practiced by dermatologic surgeons across the world. However, common complications associated with this procedure include bleeding, tissue lumps, and scarring, among others.
For instance, Allergan plc’s integrated fat transfer system REVOLVE can cause adverse effects such as fat necrosis, cyst formation, infection, chronic foreign body response, allergic reactions, and inflammation. Furthermore, fat grafting systems should be used with extreme caution for patients suffering from chronic medical conditions such as diabetes, heart disease, lung disease, circulatory system disease, and obesity. These types of post grafting complications affect the adoption of the process, as many patients may opt not to go ahead with the procedure.
What are the Key Factors Responsible for Market Expansion?
Increasing prevalence of scar contractures and growing demand for correction of contour deformities in reconstructed breasts are expected to drive demand for autologous fat grafting. Patients of accidents, burns, surgeries, etc., can develop abnormal and painful scars that lead to the hardening or tightening of the skin, which mostly results in the limitation of motion. Unfortunately, several of these patients sustain serious scarring and life-long physical disabilities. According to the American Burn Association, around 450,000 patients receive hospital and emergency room treatment for burns annually in the U.S., and 96.7% of these patients suffer from serious scarring, life-long physical disabilities, and adjustment difficulties. Most often, skin in the region of scars cannot be fully recovered even with aesthetic treatments that are currently available in the market. However, with advancements in autologous fat grafting, it has become possible to treat such scarring from both, an aesthetic and functional point of view. Using autologous fat grafting, the skin in the scarred region becomes softer and more flexible & extensible, and the color of the graft becomes almost the same as that of the original skin.
Patients treated with autologous fat grafting have also reported that they experienced less pain and improved scar elasticity. Improvements can be noticed as early as within two weeks.
Interested to Procure The Data
How are Favorable Reimbursement Policies Impacting Global Demand?
Various healthcare and government insurance providers are offering reimbursement facilities for the diagnosis and treatment of skin burns, scars, and skin-related complications. These are covered under Medicare, Medicaid, and private health insurance plans for all healthcare services, which is contributing to the growth of the market.
Government agencies, private insurers, and other payers regulate the provision of coverage for a particular procedure and provide reimbursement to hospitals for medical treatment. In the U.S., hospitals reimburse at a fixed rate based on the Diagnosis-related Group (DRG) established by the United States Centers for Medicare and Medicaid Services
Autologous fat grafting is one of the most expensive methods, due to which, initial treatment and post-treatment cost is likely to be a financial burden for the family of a patient.
However, this procedure has been the most preferred choice among aesthetic specialists due to its simplicity and effectiveness. Medicare and other healthcare insurance providers in the U.S. are facilitating the provision of reliable autologous fat grafting treatment options.
Why is Demand for Autologous Fat Grafting Rising in the U.S.?
Growing preference for aesthetic cosmetic procedures such as autologous fat grafting in the U.S. is expected to support the growth of the in the country. According to the American Society for Aesthetic Plastic Surgery (ASAPS), around two-third of aesthetic treatments performed by plastic surgeons are nonsurgical procedures such as autologous fat transfer, which help avoid complications associated with allogeneic fillers and implants.
Moreover, they are highly accessible and cost-effective. Spending on aesthetic cosmetic procedures in the U.S., which includes surgical and non-surgical procedures, was over US$ 16.7 Bn in 2019.
Similarly increasing demand for reconstruction procedure in the U.S. is another major factor responsible for the growth of the market. For instance, in 2018, 6.2 Mn people underwent augmentation and reconstruction procedures in the U.S., out of which, adoption % of autologous fat grafting procedures was 2.2%.
Why is Innovation in Autologous Fat Grafting Key to Succeed in the U.K.?
Continued investments in product development have led to the commercialization of autologous fat transfer systems and accessories in the U.K. Additionally, increase in research & development has led to the incorporation of these products in various aesthetic procedures, for achieving faster scar and skin recovery.
Availability of technical resources and enhanced knowledge base from research collaborations tend to improve the quality of autologous fat grafting and its success rates, thereby driving market growth in Europe, especially in the U.K.
In 2019, the UK population was 66.65 million, and among them, 40 per 100,000 people underwent cosmetic surgeries. Such number indicates huge demand for cosmetic procedures in the U.K. Increasing number of cosmetic surgeries such as fat grafting procedures is supplementing market expansion in the U.K.
Why is Demand for Autologous Fat Grafting High in Japan?
Growing number of aesthetic and cosmetic procedures in Japan is expected to drive demand for autologous fat grafting in the country. For instance, according to an international study on aesthetic and cosmetic procedures, 610,000 cosmetic surgeries were performed in Japan in 2017.
Also, growing preference for non-invasive procedures such as autologous fat grafting with minimal incisions has increased. In 2017, around 100,000 non-surgical procedures were done in Japan, which indicates wide growth scope for autologous fat grafting industry players.
How is Rising Adoption of Breast Augmentation Increasing the Market Share of Brazil?
Brazil accounted for 28.4% of all of the cosmetic procedures performed in 2018 across the world. Breast augmentation is one of the top performed cosmetic surgeries in Brazil. In 2018, around 270,000 breast augmentation procedures were performed in Brazil.
However, in the immediate as well as during the post-operative period, the contour of the reconstructed breast is likely to become insufficient, and additional improvement of the breast shape and contour at the time of other secondary processes is likely to lead to more serious aesthetic complications. With fat grafts, such inefficient outcomes and associated complications become almost negligible.
As the technique offers promising intervention for the management of a common and distressing problem, demand for fat grafting products for post-mastectomy breast reconstruction is on the rise. Growing demand for autologous fat grafting for the correction of contour deformities in reconstructed breasts is expected to surge market growth in Brazil.
Why Do Integrated Fat Transfer Systems Have a Higher Market Share?
An integrated fat transfer system is used commercially for the aspiration, filtering, harvesting, and transferring of autologous adipose tissues or fats for aesthetic body contouring. These systems are intended to eliminate local deposits of additional fat through minor incisions, and consequently transfer the tissue back to the patient. Integrated fat transfer continues to gather adhesion as a sustainable alternative to invasive cosmetic surgery, as demand for younger skin with minimal skin invasion remains high.
Furthermore, benefits of integrated fat transfer procedures, including rapid recovery with lesser allergic risks and reduced downtime, are encouraging demand globally. Key manufacturers are focusing more on the development of integrated fat transfer systems to meet consumer demand.
How Big is the Opportunity in Breast Augmentation for Autologous Fat Grafting Product Manufacturers?
Increasing number of scars due to burns and accidents, rising prevalence of skin disorders, and lifestyle changes provide additional opportunities for growth of autologous fat grafting providers.
Also, favorable reimbursement schemes in the U.S. are expected to fuel demand for autologous fat grafting products over the forecast period. Furthermore, availability of fast-track approval of medical devices and systems provides an opportunity for innovations and advancements in autologous fat grafting systems.
For example, in Dec 2018, the FDA released its vision for its “Breakthrough Devices Program”, outlining its plans to speed new devices that help in diagnosis and treatment. Autologous fat grafting is one of the most commonly implemented treatments in reconstructive and aesthetic surgery. The number of aesthetic fat grafting procedures increased by over 48% from 2014 to 2018.
Fact.MR has profiled the following prominent autologous fat grafting stakeholders in its report:Acquisitions and new product launches among global and regional market players is a characteristic phenomenon of the overall competition in the market.
- For instance, in May 2020, AbbVie acquired Allergan plc to include several new products in the aesthetics and women's health portfolio.
- In 2017, Allergan plc acquired Lifecell Corp. This acquisition was expected to help expand Allergan’s autologous fat grafting solutions and dermal matrix products, along with creating opportunities for the sales of new products.
- In 2018, Allergan acquired Elastagen, an exciting clinical-stage company with an advanced tissue repair platform based on tropoelastin.
- In 2019, Innova Medical collaborated with Medical Device Resource Corporation (MD Resource), a manufacturer and distributor of liposuction and fat transfer systems.
- Tulip has made its mark with the invention of the patented Syringe System, the patented SuperLuerLok hub, and the proprietary Cell Friendly technology.
Historical Data Available for
US$ Mn for Value
Key Regions Covered
Key Countries Covered
Key Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon Request
Key Segments of Market
- Integrated Fat Transfer Systems
- Aspiration and Harvesting Systems
- Liposuction Systems
- Fat Processing Systems
- De-epithelialization Devices
- Fat Injection Cannulas
- Fat Harvesting Cannulas
- LuerLok Infiltrator Cannulas
- Cannula Connectors & Single Use Fat Transfer
- Tubing Sets
- Autologous Fat Grafting for Breast Augmentation
- Autologous Fat Grafting for Buttock Augmentation
- Facial Fat Grafting
- Autologous Fat Grafting for Hand Rejuvenation
- Autologous Fat Grafting at Hospitals
- Autologous Fat Grafting at On-site Clinics
- Autologous Fat Grafting at Plastic Surgery Centers
- North America
- Latin America
- South Asia
- East Asia
- The Middle East and Africa
- FAQs -
Global market to register a CAGR close to 10% across the 2021-2031 assessment period. Increasing shift from invasive to non-invasive aesthetic treatments and growing acceptance of aesthetic cosmetic procedures are anticipated to dr
The U.S. is expected to pivot expansion due to technological advancements and the presence of major players offering autologous fat grafting products in the country.
Leading players in the market are introducing innovative products to retain and increase their market share. Currently, they are consistently making changes in their product categories and technologies to enhance their autologous fat grafting products&
Prominent players operating in the market landscape include AbbVie Inc. (Allergan plc), Sisram Medical, Ltd (Alma Lasers), Plus Therapeutics, Inc. (Cytori Therapeutics, Inc.), Genesis Biosystems, Inc., Black Tie Medical Inc. (Tulip Medical Inc.), Ranfa